Gene · 9775
Papers1,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,749
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Glioblastoma CircularRNAome. | Int J Mol Sci | 2023 | 37833993 | PubTator, text mining | PubMed |
| DDX52 gene expression in LUAD tissues indicates potential as a prognostic biomarker and therapeutic target. | Sci Rep | 2023 | 37833424 | PubTator, text mining | PubMed |
| Silencing circSERPINE2 restrains mesenchymal stem cell senescence via the YBX3/PCNA/p21 axis. | Cell Mol Life Sci | 2023 | 37831180 | PubTator, text mining | PubMed |
| LncRNA LINC00667 gets involved in clear cell renal cell carcinoma development and chemoresistance by regulating the miR-143-3p/ZEB1 axis. | Aging (Albany NY) | 2023 | 37827696 | PubTator, text mining | PubMed |
| An interaction between eIF4A3 and eIF3g drives the internal initiation of translation. | Nucleic Acids Res | 2023 | 37811880 | PubTator, text mining | PubMed |
| Role of LncRNA MIR99AHG in breast cancer: Bioinformatic analysis and preliminary verification. | Heliyon | 2023 | 37809464 | PubTator, text mining | PubMed |
| First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma. | Res Sq | 2023 | 37790486 | PubTator, text mining | PubMed |
| Identification of m6A suppressor EIF4A3 as a novel cancer prognostic and immunotherapy biomarker through bladder cancer clinical data validation and pan-cancer analysis. | Sci Rep | 2023 | 37777564 | PubTator, text mining | PubMed |
| The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma. | Front Pharmacol | 2023 | 37767397 | PubTator, text mining | PubMed |
| Evaluation of Dimercaptosuccinic Acid-Coated Iron Nanoparticles Immunotargeted to Amyloid Beta as MRI Contrast Agents for the Diagnosis of Alzheimer's Disease. | Cells | 2023 | 37759500 | PubTator, text mining | PubMed |
| EGCG-LYS Fibrils-Mediated CircMAP2K2 Silencing Decreases the Proliferation and Metastasis Ability of Gastric Cancer Cells in Vitro and in Vivo. | Adv Sci (Weinh) | 2023 | 37752765 | PubTator, text mining | PubMed |
| Activity Guided Azide-methyllysine Photo-trapping for Substrate Profiling of Lysine Demethylases. | J Am Chem Soc | 2023 | 37703462 | PubTator, text mining | PubMed |
| Long noncoding RNA SNHG16 regulates TLR4-mediated autophagy and NETosis formation in alveolar hemorrhage associated with systemic lupus erythematosus. | J Biomed Sci | 2023 | 37700342 | PubTator, text mining | PubMed |
| Various LncRNA Mechanisms in Gene Regulation Involving miRNAs or RNA-Binding Proteins in Non-Small-Cell Lung Cancer: Main Signaling Pathways and Networks. | Int J Mol Sci | 2023 | 37686426 | PubTator, text mining | PubMed |
| Differentially expressed non-coding RNAs and their regulatory networks in liver cancer. | Heliyon | 2023 | 37662778 | PubTator, text mining | PubMed |
| Tumor cell-derived exosomes regulate macrophage polarization: Emerging directions in the study of tumor genesis and development. | Heliyon | 2023 | 37662730 | PubTator, text mining | PubMed |
| TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation. | Cell Rep | 2023 | 37659079 | PubTator, text mining | PubMed |
| Transposable elements as tissue-specific enhancers in cancers of endodermal lineage. | Nat Commun | 2023 | 37658059 | PubTator, text mining | PubMed |
| Role of Circular RNAs in Atherosclerosis through Regulation of Inflammation, Cell Proliferation, Migration, and Apoptosis: Focus on Atherosclerotic Cerebrovascular Disease. | Medicina (Kaunas) | 2023 | 37629751 | PubTator, text mining | PubMed |
| Virus Infection and mRNA Nuclear Export. | Int J Mol Sci | 2023 | 37628773 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9775/papers?page=12